S&P 500   5,047.77 (-0.28%)
DOW   37,771.67 (+0.10%)
QQQ   430.68 (-0.09%)
AAPL   170.64 (-1.19%)
MSFT   415.70 (+0.50%)
META   499.13 (-0.22%)
GOOGL   153.63 (-0.79%)
AMZN   183.30 (-0.17%)
TSLA   155.51 (-3.70%)
NVDA   869.28 (+1.08%)
AMD   163.27 (+1.84%)
NIO   3.76 (-3.34%)
BABA   69.79 (-1.18%)
T   16.01 (-1.42%)
F   12.05 (-1.47%)
MU   119.82 (-1.28%)
GE   154.09 (+0.25%)
CGC   6.65 (-4.73%)
DIS   113.43 (+0.42%)
AMC   2.56 (+3.64%)
PFE   25.91 (+0.00%)
PYPL   63.40 (-0.17%)
XOM   118.57 (-0.93%)
S&P 500   5,047.77 (-0.28%)
DOW   37,771.67 (+0.10%)
QQQ   430.68 (-0.09%)
AAPL   170.64 (-1.19%)
MSFT   415.70 (+0.50%)
META   499.13 (-0.22%)
GOOGL   153.63 (-0.79%)
AMZN   183.30 (-0.17%)
TSLA   155.51 (-3.70%)
NVDA   869.28 (+1.08%)
AMD   163.27 (+1.84%)
NIO   3.76 (-3.34%)
BABA   69.79 (-1.18%)
T   16.01 (-1.42%)
F   12.05 (-1.47%)
MU   119.82 (-1.28%)
GE   154.09 (+0.25%)
CGC   6.65 (-4.73%)
DIS   113.43 (+0.42%)
AMC   2.56 (+3.64%)
PFE   25.91 (+0.00%)
PYPL   63.40 (-0.17%)
XOM   118.57 (-0.93%)
S&P 500   5,047.77 (-0.28%)
DOW   37,771.67 (+0.10%)
QQQ   430.68 (-0.09%)
AAPL   170.64 (-1.19%)
MSFT   415.70 (+0.50%)
META   499.13 (-0.22%)
GOOGL   153.63 (-0.79%)
AMZN   183.30 (-0.17%)
TSLA   155.51 (-3.70%)
NVDA   869.28 (+1.08%)
AMD   163.27 (+1.84%)
NIO   3.76 (-3.34%)
BABA   69.79 (-1.18%)
T   16.01 (-1.42%)
F   12.05 (-1.47%)
MU   119.82 (-1.28%)
GE   154.09 (+0.25%)
CGC   6.65 (-4.73%)
DIS   113.43 (+0.42%)
AMC   2.56 (+3.64%)
PFE   25.91 (+0.00%)
PYPL   63.40 (-0.17%)
XOM   118.57 (-0.93%)
S&P 500   5,047.77 (-0.28%)
DOW   37,771.67 (+0.10%)
QQQ   430.68 (-0.09%)
AAPL   170.64 (-1.19%)
MSFT   415.70 (+0.50%)
META   499.13 (-0.22%)
GOOGL   153.63 (-0.79%)
AMZN   183.30 (-0.17%)
TSLA   155.51 (-3.70%)
NVDA   869.28 (+1.08%)
AMD   163.27 (+1.84%)
NIO   3.76 (-3.34%)
BABA   69.79 (-1.18%)
T   16.01 (-1.42%)
F   12.05 (-1.47%)
MU   119.82 (-1.28%)
GE   154.09 (+0.25%)
CGC   6.65 (-4.73%)
DIS   113.43 (+0.42%)
AMC   2.56 (+3.64%)
PFE   25.91 (+0.00%)
PYPL   63.40 (-0.17%)
XOM   118.57 (-0.93%)
NYSE:SENS

Senseonics (SENS) Stock Price, News & Analysis

$0.44
+0.01 (+1.35%)
(As of 10:39 AM ET)
Today's Range
$0.44
$0.45
50-Day Range
$0.44
$0.73
52-Week Range
$0.43
$1.05
Volume
563,499 shs
Average Volume
2.44 million shs
Market Capitalization
$235.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.25

Senseonics MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
186.0% Upside
$1.25 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.13) to ($0.11) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.42 out of 5 stars

Medical Sector

894th out of 928 stocks

Process Control Instruments Industry

12th out of 12 stocks

SENS stock logo

About Senseonics Stock (NYSE:SENS)

Senseonics Holdings, Inc., a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

SENS Stock Price History

SENS Stock News Headlines

REVEALED: Elon Musk’s Secret A.I. Facility?
I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.
REVEALED: Elon Musk’s Secret A.I. Facility?
I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.
Q4 2023 Senseonics Holdings Inc Earnings Call
Senseonics: Q4 Earnings Snapshot
Here's what to expect from Senseonics's earnings
SENS Jan 2026 1.500 put
SENS Mar 2024 0.500 call
Senseonics Holdings Inc
Senseonics Holdings Inc SENS
See More Headlines
Receive SENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Senseonics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/29/2024
Today
4/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Process control instruments
Sub-Industry
N/A
Employees
132
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.25
High Stock Price Target
$2.00
Low Stock Price Target
$0.50
Potential Upside/Downside
+186.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$-60,390,000.00
Net Margins
-270.13%
Pretax Margin
-269.73%

Debt

Sales & Book Value

Annual Sales
$22.39 million
Book Value
$0.07 per share

Miscellaneous

Free Float
502,012,000
Market Cap
$231.96 million
Optionable
N/A
Beta
0.87
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Dr. Timothy T. Goodnow Ph.D. (Age 62)
    President, CEO & Director
    Comp: $1.34M
  • Dr. Mukul Jain (Age 51)
    Chief Operating Officer
    Comp: $767.65k
  • Mr. Kenneth L. Horton (Age 57)
    General Counsel & Corporate Development Advisor
    Comp: $702.33k
  • Dr. Francine Ratner Kaufman M.D. (Age 72)
    Chief Medical Officer & Director
  • Mr. Frederick T. Sullivan (Age 42)
    CFO, Secretary & Treasurer

SENS Stock Analysis - Frequently Asked Questions

Should I buy or sell Senseonics stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SENS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SENS, but not buy additional shares or sell existing shares.
View SENS analyst ratings
or view top-rated stocks.

What is Senseonics' stock price target for 2024?

2 Wall Street analysts have issued 12 month price targets for Senseonics' stock. Their SENS share price targets range from $0.50 to $2.00. On average, they expect the company's stock price to reach $1.25 in the next twelve months. This suggests a possible upside of 186.0% from the stock's current price.
View analysts price targets for SENS
or view top-rated stocks among Wall Street analysts.

How have SENS shares performed in 2024?

Senseonics' stock was trading at $0.5701 at the beginning of the year. Since then, SENS stock has decreased by 23.3% and is now trading at $0.4371.
View the best growth stocks for 2024 here
.

How were Senseonics' earnings last quarter?

Senseonics Holdings, Inc. (NYSE:SENS) posted its quarterly earnings results on Thursday, February, 29th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.04) by $0.01. The company earned $8 million during the quarter, compared to analyst estimates of $7.62 million. Senseonics had a negative net margin of 270.13% and a negative trailing twelve-month return on equity of 146.90%.

What guidance has Senseonics issued on next quarter's earnings?

Senseonics issued an update on its FY 2023 earnings guidance on Tuesday, January, 30th. The company provided EPS guidance of for the period. The company issued revenue guidance of $22.0 million-$22.0 million, compared to the consensus revenue estimate of $21.8 million.

When did Senseonics IPO?

Senseonics (SENS) raised $45 million in an initial public offering (IPO) on Friday, March 18th 2016. The company issued 15,800,000 shares at $2.85 per share. Leerink Partners, Canaccord Genuity and Raymond James acted as the underwriters for the IPO and BTIG was co-manager.

How do I buy shares of Senseonics?

Shares of SENS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:SENS) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners